Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Cronos Group Inc (CRON)

Cronos Group Inc (CRON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cronos Group Inc 111 PETER STREET SUITE 300 TORONTO A6 M5V 2H1 CAN

www.thecronosgroup.com P: 416-504-0004

Description:

Cronos Group, Inc. engages in the investment in firms which are licensed to produce and sell medical marijuana. Its portfolio includes In The Zone, Peace Naturals, Whistler Medical Marijuana Co., ABcann, Hydropothecary, Vert Medical and Evergreen Medicinal Supply. Cronos Group Inc., formerly known as PharmaCan Capital Corp., is headquartered in Toronto, Canada.

Key Statistics

Overview:

Market Capitalization, $K 909,829
Enterprise Value, $K 240,539
Shares Outstanding, K 382,281
Annual Sales, $ 87,240 K
Annual Net Income, $ -73,960 K
Last Quarter Sales, $ 25,290 K
Last Quarter Net Income, $ -2,240 K
EBIT, $ -70,760 K
EBITDA, $ -62,650 K
60-Month Beta 1.00
% of Insider Shareholders 6.90%
% of Institutional Shareholders 8.71%
Float, K 355,904
% Float 93.10%
Short Volume Ratio 0.47

Growth:

1-Year Return 34.59%
3-Year Return -66.21%
5-Year Return -82.01%
5-Year Revenue Growth 620.40%
5-Year Earnings Growth -25.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.01 on 05/09/24
Next Earnings Date 08/13/24
Earnings Per Share ttm -0.08
EPS Growth vs. Prev Qtr 80.00%
EPS Growth vs. Prev Year 66.67%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

CRON Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -3.06%
Return-on-Assets % -2.97%
Profit Margin % -84.78%
Debt/Equity 0.00
Price/Sales 10.30
Price/Cash Flow N/A
Price/Book 0.84
Book Value/Share 2.81
Interest Coverage -0.11
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar